...
首页> 外文期刊>JAIDS: Journal of acquired immune deficiency syndromes >Characterization of CD4+ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients
【24h】

Characterization of CD4+ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients

机译:HIV,丙型肝炎病毒和HIV / HCV合并感染患者中CD4 + T细胞免疫激活和白介素10水平的表征

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: HIV/hepatitis C virus (HCV)-coinfected patients have accelerated liver disease compared with HCV monoinfection. In HIV-positive patients with viral suppression, data comparing inflammatory cytokines and immune activation between HIV/HCV coinfection with chronic hepatitis C (CHC) to HIV/HCV-seropositive patients with cleared HCV are limited. METHODS: Fifty-nine age- and sex-matched patients were stratified: (1) HIV monoinfection (n = 15); (2) HCV monoinfection with CHC (n = 15); (3) HIV/HCV coinfection with CHC (n = 14); and (4) HIV/HCV seropositive with cleared HCV (n = 15). All HIV-positive patients had undetectable HIV viremia, and median CD4 was 420 cells per microliter. Liver fibrosis was assessed in each subject using transient elastography. Cells were collected for CD4 and CD8 immune activation (CD38/HLA-DR) markers via flow cytometry and plasma for luminex-multiplex cytokine assays. RESULTS: CD38+HLA-DR+ expression on CD4+ T cells was significantly increased in HIV/HCV coinfection with CHC (7%) versus HCV monoinfection (4%) (P = 0.012). CD4+ total HLA-DR expression was significantly increased in HIV/HCV coinfection with CHC (43%) versus HIV monoinfection (31%) (P = 0.010) and HIV/HCV seropositive with cleared HCV (38%) (P = 0.046). Total CD4+CD38+ and CD4 +CD38+HLA-DR expression was significantly higher in HIV monoinfection (23% and 18%) than HCV moninfection (13%, P = 0.002% and 9%, P = 0.001, respectively). Interleukin 10 levels were significantly lower in HIV monoinfection versus HIV/HCV coinfection with CHC (P = 0.0002). In multivariate analysis, severe fibrosis was associated with lower expression of CD4 +CD38+HLA-DR and CD4+ total CD38+ than mild-moderate fibrosis (P = 0.03 and 0.03, respectively). CONCLUSIONS: CD4+ immune activation with HLA-DR expression in HIV/HCV coinfection with well-controlled HIV may arise from chronic HCV viremia. Conversely, CD4+CD38+ expression may be driven by underlying HIV infection. CD4 immune activation was unexpectedly found to be associated with decreased liver fibrosis.
机译:背景:与HCV单一感染相比,HIV /丙型肝炎病毒(HCV)合并感染的患者会加速肝脏疾病。在具有病毒抑制作用的HIV阳性患者中,比较将HIV / HCV合并慢性C型肝炎(CHC)与HIV / HCV阳性HCV阳性患者之间的炎症细胞因子和免疫激活进行比较的数据有限。方法:对59名年龄和性别匹配的患者进行分层:(1)HIV单一感染(n = 15); (2)丙型肝炎病毒感染HCC(n = 15); (3)HIV / HCV合并CHC(n = 14); (4)清除了HCV的HIV / HCV血清反应阳性(n = 15)。所有HIV阳性患者均检测不到HIV病毒血症,中位数CD4为420细胞/微升。使用瞬时弹性成像法评估每个受试者的肝纤维化。通过流式细胞术和血浆收集细胞的CD4和CD8免疫激活(CD38 / HLA-DR)标记,以进行Luminex多重细胞因子测定。结果:与HCV单一感染(4%)相比,CHC感染HIV / HCV合并感染的CD4 + T细胞上CD38 + HLA-DR +表达显着增加(P = 0.012)。与CHC合并感染的HIV / HCV(43%)相比,HIV / HCV合并感染的CD4 +总HLA-DR表达显着增加(43%)(P = 0.010),HCV阳性的HIV / HCV血清阳性(38%)(P = 0.046)。在HIV单次感染中,总CD4 + CD38 +和CD4 + CD38 + HLA-DR表达(分别为23%和18%)显着高于HCV单感染(分别为13%,P = 0.002%和9%,P = 0.001)。与CHC相比,HIV单一感染的白细胞介素10水平显着低于HIV / HCV合并感染(P = 0.0002)。在多变量分析中,与轻度中度纤维化相比,严重纤维化与CD4 + CD38 + HLA-DR和CD4 +总CD38 +的表达降低有关(分别为P = 0.03和0.03)。结论:在HIV / HCV合并感染且控制良好的HIV中,具有HLA-DR表达的CD4 +免疫激活可能源于慢性HCV病毒血症。相反,CD4 + CD38 +表达可能受潜在的HIV感染驱动。意外地发现CD4免疫激活与肝纤维化减少有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号